Ventyx Biosciences, Inc. announced that it has entered into a Stock Purchase Agreement with certain qualified institutional buyers and institutional accredited investors pursuant to which the company agreed to sell to the Purchasers 11,174,000 shares of the company?s common stock, par value $0.0001 per share, at an offering price of $8.95 per share for the gross proceeds of approximately $100,000,000 on March 6, 2024. The Private Placement is expected to close on March 11, 2024, subject to the satisfaction of customary closing conditions.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.93 USD | +10.04% | -8.76% | +81.38% |
May. 09 | Transcript : Ventyx Biosciences, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Ventyx Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+81.38% | 316M | |
+2.97% | 108B | |
+10.21% | 104B | |
+3.76% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- VTYX Stock
- News Ventyx Biosciences, Inc.
- Ventyx Biosciences, Inc. announced that it expects to receive $100.0073 million in funding